%PDF-1.4
%
62 0 obj
<>
endobj
59 0 obj
<>
endobj
116 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2005-02-02T15:19:23Z
2024-03-28T06:49:19-07:00
QuarkXPressª: AdobePS 8.8.0 (301)
2024-03-28T06:49:19-07:00
application/pdf
Heather
2004-268.mar
uuid:27bad2ad-1dd2-11b2-0a00-4108277d8900
uuid:27bad2b0-1dd2-11b2-0a00-d30000000000
endstream
endobj
48 0 obj
<>
endobj
49 0 obj
<>
endobj
63 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 30 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 32 0 R/Type/Page>>
endobj
12 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 34 0 R/Type/Page>>
endobj
15 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 36 0 R/Type/Page>>
endobj
18 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 38 0 R/Type/Page>>
endobj
21 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 40 0 R/Type/Page>>
endobj
24 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 42 0 R/Type/Page>>
endobj
142 0 obj
[146 0 R]
endobj
143 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
13.5 787.5 585 -783 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.01511 Tc 0.02499 Tw 8 0 0 8 73.868 737.0293 Tm
[(osteoarthritis in primary care research. J Rheumatol 1999;26:1)36.7 (129-33.)]TJ
-0.03011 Tc -2.175 -1.225 Td
[(2)-30.1 (4)-30.1 (.)-905.1 (Kellgren J, Lawrence J. )54.8 (Atlas of standard radiographs. )17.7 (The epidemiology)]TJ
2.175 -1.225 Td
(of chronic rheumatism. Oxford: Blackwell Scientific; 1963.)Tj
-0.00011 Tc -2.175 -1.225 Td
[(25.)-875.1 (Bellamy N, Buchanan )17.7 (WW)91.7 (, Goldsmith CH, Campbell J, Stitt L)73.9 (W)91.9 (.)]TJ
2.175 -1.225 Td
[(V)110.8 (alidation study of )17.7 (WOMAC: a health status instrument for)]TJ
0 -1.225 TD
(measuring clinically important patient relevant outcomes to)Tj
T*
(antirheumatic drug therapy in patients with osteoarthritis of the hip)Tj
T*
(or knee. J Rheumatol 1988;15:1833-40.)Tj
-2.175 -1.225 Td
[(26.)-875.1 (Bellamy N, Campbell J, Stevens J, Pilch L, Stewart C, Mahmood)]TJ
2.175 -1.225 Td
[(Z. )17.7 (V)110.8 (alidation study of a computerized version of the )17.7 (W)79.9 (estern)]TJ
T*
[(Ontario and McMaster Universities )17.7 (V)128.9 (A3.0 Osteoarthritis Index. )]TJ
T*
(J Rheumatol 1997;24:2413-5.)Tj
-2.175 -1.225 Td
[(27.)-875.1 (Bellamy N. Outcome measurement in osteoarthritis clinical trials. )]TJ
2.175 -1.225 Td
(J Rheumatol 1995;22:49-51.)Tj
-2.175 -1.225 Td
[(28.)-875.1 (Koke )54.8 (A, Heuts P)110.7 (,)-0.1 ( )17.7 (Vlaeyen J, )17.7 (W)79.9 (eber )17.7 (W)91.8 (. Meetinstrumenten)]TJ
2.175 -1.225 Td
(chronische pijn: deel 1 functionele status. Maastricht: 1999)Tj
T*
[([internet] [cited January 3, 2005]. )54.8 (A)74 (vailable from)]TJ
0 Tw T*
[(http://www)64.8 (.pijn.com/medici/meet_status.htm)]TJ
0.02499 Tw -2.175 -1.225 Td
[(29.)-875.1 (van der Zee KI, Sanderman R. Het meten van de algemene gezond-)]TJ
2.175 -1.225 Td
(heidstoestand met de RAND-36; een handleiding. Groningen:)Tj
T*
(Noordelijk Centrum voor Gezondheidsvraagstukken; 1993.)Tj
-2.175 -1.2125 Td
[(30.)-875.1 (Lorig K, Chastain R, Ung E, Shoor S, Holman H. Development and)]TJ
2.175 -1.2125 Td
[(evaluation of a scale to measure perceived self-ef)17.7 (ficacy in people)]TJ
0 -1.2125 TD
[(with arthritis. )54.8 (Arthritis Rheum 1989;32:37-44.)]TJ
-2.175 -1.2125 Td
[(31.)-875.1 (T)69.9 (aal E, Rasker J, Seydel E, )17.7 (W)39.8 (iegman O. Health status, adherence)]TJ
2.175 -1.2125 Td
[(with health recommendations, self-ef)17.7 (ficacy and social support in)]TJ
-0.01511 Tc T*
(patients with rheumatoid arthritis. Patient Educ Couns 1993;20:63-76.)Tj
-0.00011 Tc -2.175 -1.2125 Td
[(32.)-875.1 (Kori SH, Miller RP)110.7 (, )17.7 (T)69.9 (odd DD. Kinesiophobia: )54.8 (A)-220.1 (new view of)]TJ
2.175 -1.2125 Td
[(chronic pain behavior)54.8 (. Pain Management 1990;3:35-43.)]TJ
-2.175 -1.2125 Td
[(33.)-875.1 (Heuts PH, )17.7 (Vlaeyen JW)91.7 (, Roelofs J, et al. Pain-related fear and daily)]TJ
2.175 -1.2125 Td
[(functioning in patients with osteoarthritis. Pain 2004;1)36.8 (10:228-35.)]TJ
-2.175 -1.2125 Td
[(34.)-875.1 (Goubert L, Crombez G, )17.7 (Vlaeyen J, et al. )17.7 (The )17.7 (T)69.9 (ampa Schaal voor)]TJ
2.175 -1.2125 Td
(Kinesiofobie: Psychometrische karakteristieken en normering [The)Tj
T*
[(T)69.9 (ampa scale for Kinesiophobia: Psychometric properties and)]TJ
T*
(norms]. Gedrag en Gezondheid 2000;28:54-62.)Tj
-2.175 -1.2125 Td
[(35.)-875.1 (Heuts PH, de Bie RA, Dijkstra )54.8 (A, et al. )54.8 (Assessment of readiness to)]TJ
2.175 -1.2125 Td
(change in patients with osteoarthritis. Development and application)Tj
T*
(of a new questionnaire. Clin Rehabil 2005;\(in press\).)Tj
-2.175 -1.2125 Td
[(36.)-875.1 (T)69.9 (aal E, Rasker JJ, )17.7 (W)39.8 (iegman O. Patient education and self-)]TJ
2.175 -1.2125 Td
[(management in the rheumatic diseases: a self-ef)17.7 (ficacy approach.)]TJ
T*
(Arthritis Care Res 1996;9:229-38.)Tj
-2.175 -1.2125 Td
[(37.)-875.1 (Bandura )54.8 (A. Self-ef)17.7 (ficacy: the exercise of control. New )36.7 (Y)99.8 (ork:)]TJ
2.175 -1.2125 Td
(Freeman and Company; 1997.)Tj
-2.175 -1.2125 Td
[(38.)-875.1 (Linton SJ. )17.7 (The challenge of preventing chronic musculoskeletal)]TJ
2.175 -1.2125 Td
[(pain. In: Gebhart GF)79.7 (, Hammond DL, Jensen )17.7 (TS, editors.)]TJ
T*
[(Proceedings of the 7th )17.7 (W)79.9 (orld Congress on Pain. Seattle: IASP)]TJ
T*
(Press; 1994:149-66.)Tj
-2.175 -1.2125 Td
[(39.)-875.1 (Linton SJ. Utility of cognitive-behavioral pychological treatments.)]TJ
2.175 -1.2125 Td
[(In: Nachemson )54.8 (AL, Jonsson E, editors. Neck and back pain: the)]TJ
T*
(scientific evidence of causes, diagnosis, and treatment.)Tj
T*
[(Philadelphia: Lippincott, )17.7 (W)39.9 (illiams and )17.7 (W)39.8 (ilkins; 2000.)]TJ
-2.175 -1.2125 Td
[(40.)-875.1 (Linton SJ. Environmental and learning factors in the development)]TJ
2.175 -1.2125 Td
[(of chronic pain and disability)64.8 (. In: Price DD, Bushnell MC, editors.)]TJ
T*
(Psychological methods of pain control: basic science and clinical)Tj
T*
[(perspectives. Seattle: IASP)-238.2 (Press; 2004:143-67.)]TJ
-2.175 -1.2125 Td
[(41.)-875.1 (Linton SJ, R)39.7 (yber)17.7 (g M. )54.8 (A)-220.1 (cognitive-behavioral group intervention as)]TJ
2.175 -1.2125 Td
(prevention for persistent neck and back pain in a non-patient)Tj
T*
(population: a randomized controlled trial. Pain 2001;90:83-90.)Tj
-2.175 -1.2125 Td
[(42.)-875.1 (V)128.9 (on Korf)17.7 (f M. Perspectives on management of back pain in primary)]TJ
2.175 -1.2125 Td
[(care. In: Gebhart GF)79.7 (, Hammond DL, Jensen )17.7 (TS, editors.)]TJ
T*
[(Proceedings of the 7th )17.7 (W)79.9 (orld Congress on Pain. Seattle: IASP)]TJ
T*
[(Press; 1994:97-1)36.8 (10.)]TJ
-2.175 -1.2125 Td
[(43.)-875.1 (V)128.9 (on Korf)17.7 (f M. Pain management in primary care: an individualized)]TJ
2.175 -1.2125 Td
[(stepped-care approach. In: Gatchel RJ, )17.7 (T)35 (urk DC, editors.)]TJ
T*
[(Psychosocial factors in pain: critical perspectives. New )36.8 (Y)99.8 (ork:)]TJ
T*
(Guilford Press; 1999:360-73.)Tj
30.825 79.0625 Td
[(44.)-875.1 (Moore JE, )17.7 (V)128.9 (on Korf)17.7 (f M, Cherkin D, Saunders K, Lorig K. )54.8 (A)]TJ
2.175 -1.225 Td
(randomized trial of a cognitive-behavioral program for enhancing)Tj
0 -1.225 TD
(back pain self care in a primary care setting. Pain 2000;88:145-53.)Tj
-2.175 -1.225 Td
[(45.)-875.1 (Morley S, Eccleston C, )17.7 (W)39.8 (i)0.1 (lliams )54.8 (A. Systematic review and meta-)]TJ
2.175 -1.225 Td
(analysis of randomized controlled trials of cognitive behaviour and)Tj
T*
(behaviour therapy for chronic pain in adults, excluding headache.)Tj
T*
(Pain 1999;80:1-13.)Tj
-2.175 -1.225 Td
[(46.)-875.1 (van den Hout J, )17.7 (Vlaeyen J, Heuts P)110.7 (, Sillen )17.7 (W)91.8 (,)-0.1 ( )17.7 (W)39.8 (illen )54.8 (A. Functional)]TJ
2.175 -1.225 Td
[(disability in non-specific low back pain: )17.7 (The role of pain-related)]TJ
T*
(fear and problem-solving skills. Int J Behav Med 2001;8:134-48.)Tj
-2.175 -1.225 Td
[(47.)-875.1 (van den Hout JH, )17.7 (Vlaeyen JW)91.7 (, Heuts PH, Zijlema JH, )17.7 (W)39.8 (ijnen JA.)]TJ
2.175 -1.225 Td
(Secondary prevention of work-related disability in nonspecific low)Tj
T*
[(back pain: does problem-solving therapy help? )54.8 (A)-220.1 (randomized)]TJ
T*
(clinical trial. Clin J Pain 2003;19:87-96.)Tj
-2.175 -1.225 Td
[(48.)-875.1 (van den Hout JHC, )17.7 (Vlaeyen JWS, Kole-Snijders )54.8 (AMJ, Heuts)]TJ
2.175 -1.225 Td
[(PHTG, )17.7 (W)39.8 (illen JEHL, Sillen )17.7 (WJT)73.9 (. Graded activity and problem)]TJ
T*
(solving therapy in sub-acute non-specific low back pain.)Tj
T*
(Physiotherapy 1998;84:167.)Tj
-2.175 -1.225 Td
[(49.)-875.1 (W)39.8 (right C, Sim J. Intention-to-treat approach to data from)]TJ
2.175 -1.225 Td
[(randomized controlled trials: )54.8 (A)-220.1 (sensitivity analysis. J Clin)]TJ
T*
(Epidemiol 2003;56:833-42.)Tj
-2.175 -1.225 Td
[(50.)-875.1 (W)79.9 (arsi )54.8 (A, LaV)110.7 (alley MP)110.7 (, )17.7 (W)79.9 (ang PS, )54.8 (A)74 (vorn J, Solomon D. )54.8 (Arthritis)]TJ
2.175 -1.225 Td
[(self-management education programs. )54.8 (A)-220.1 (meta-analysis of the ef)17.7 (fect)]TJ
T*
[(on pain and disability)64.8 (. )54.8 (Arthritis Rheum 2003;48:2207-13.)]TJ
-2.175 -1.225 Td
[(51.)-875.1 (Fries JF)79.7 (, Lorig K, Holman HR. Patient self-management in)]TJ
2.175 -1.225 Td
[(arthritis? )36.8 (Y)99.8 (es! [editorial]. J Rheumatol 2003;30:1)36.8 (130-2.)]TJ
-2.175 -1.225 Td
[(52.)-875.1 (van Baar M. Ef)17.7 (fectiveness of exercise therapy in osteoarthritis of)]TJ
2.175 -1.225 Td
(hip or knee [thesis]. Utrecht: Nederlands Instituut voor Onderzoek)Tj
T*
[(van de Gezondheidsor)17.7 (g; 1998.)]TJ
-2.175 -1.225 Td
[(53.)-875.1 (van Baar M, Dekker J, Oostendorp R, et al. )17.7 (The ef)17.7 (fectiveness of)]TJ
2.175 -1.225 Td
(exercise therapy in patients with osteoarthritis of the hip or knee: a)Tj
T*
(randomized clinical trial. J Rheumatol 1998;25:2432-9.)Tj
-2.175 -1.225 Td
[(54.)-875.1 (Kerns R, Rosenber)17.7 (g R, Jamison R, Caudill M, Haythornthwaite J.)]TJ
2.175 -1.225 Td
(Readiness to adopt a self-management approach to chronic pain:)Tj
T*
(The Pain Stages of Change Questionnaire \(PSOCQ\). Pain)Tj
0 Tc 0 Tw T*
(1997;72:227-34.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.225 Td
[(55.)-875.1 (Kerns R, Rosenber)17.7 (g R. Predicting responses to self-management)]TJ
2.175 -1.225 Td
(treatments for chronic pain: application of the pain stages of change)Tj
T*
(model. Pain 2000;84:49-55.)Tj
-2.175 -1.225 Td
[(56.)-875.1 (Keefe FJ, Lefebvre JC, Kerns RD, et al. Understanding the)]TJ
2.175 -1.225 Td
(adoption of arthritis self-management: stages of change profiles)Tj
T*
(among arthritis patients. Pain 2000;87:303-13.)Tj
-2.175 -1.225 Td
[(57.)-875.1 (Jensen MP)110.7 (. Enhancing motivation to change in pain treatment. In:)]TJ
2.175 -1.225 Td
[(Gatchel RJ, )17.7 (T)35 (urk DC, editors. Psychological approaches to pain)]TJ
T*
[(management. New )36.8 (Y)99.8 (ork: Guilford Press; 1996:78-1)36.8 (1)36.8 (1)-0.1 (.)]TJ
-2.175 -1.225 Td
[(58.)-875.1 (Habib S, Morrissey SA, Helmes E. Readiness to adopt a self-)]TJ
2.175 -1.225 Td
(management approach to pain: evaluation of the pain stages of)Tj
T*
(change model in a non-pain-clinic sample. Pain 2003;104:283-90.)Tj
-2.175 -1.225 Td
[(59.)-875.1 (Jensen M, Nielson )17.7 (W)91.8 (, Romano J, Hill M, )17.7 (T)35 (urner J. Further)]TJ
2.175 -1.225 Td
(evaluation of the pain stages of change questionnaire: is the)Tj
T*
(transtheoretical model of change useful for patients with chronic)Tj
T*
(pain? Pain 2000;86:255-64.)Tj
-2.175 -1.225 Td
[(60.)-875.1 (Jensen MP)110.7 (, Nielson )17.7 (WR, )17.7 (T)35 (urner JA, Romano JM, Hill ML.)]TJ
2.175 -1.225 Td
(Readiness to self-manage pain is associated with coping and with)Tj
T*
(psychological and physical functioning among patients with)Tj
T*
(chronic pain. Pain 2003;104:529-37.)Tj
-2.175 -1.225 Td
[(61.)-875.1 (Prochaska J, DiClemente C, Norcross J. In search of how people)]TJ
2.175 -1.225 Td
[(change. )54.8 (Applications to addictive behaviors. )54.8 (Am Psychol)]TJ
0 Tc 0 Tw T*
[(1992;47:1)36.9 (102-14.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.225 Td
[(62.)-875.1 (Dijkstra )54.8 (A, )17.7 (Vlaeyen JW)91.7 (, Rijnen H, Nielson )17.7 (W)91.9 (. Readiness to adopt)]TJ
2.175 -1.225 Td
(the self-management approach to cope with chronic pain in)Tj
T*
(fibromyalgic patients. Pain 2001;90:37-45.)Tj
-2.175 -1.25 Td
[(63.)-875.1 (Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. Development)]TJ
2.175 -1.25 Td
[(and evaluation of a scale to measure perceived self-ef)17.7 (ficacy in)]TJ
0 -1.25 TD
[(people with arthritis. )54.8 (Arthritis Rheum 1989;32:37-44.)]TJ
ET
0 0 0 1 K
53.468 76.5 m
558.468 76.5 l
S
0 0 0 0 k
494.29 69.365 64.178 -15.665 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
0 Tc 0 Tw 8 0 0 8 545.468 56.4344 Tm
(549)Tj
ET
0 0 0 0 k
53.532 70.501 203 -16.998 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 54.532 56.2376 Tm
[(Heuts, et al: OA)-257.3 (self-management)]TJ
ET
0 0 0 0 k
/GS0 gs
104.631 81.483 407.5 -10.833 re
f*
0.5 w
/GS1 gs
104.631 81.483 407.5 -10.833 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_2 8 Tf
108.828 74 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
42 0 obj
<>stream
8;Z\6>B]9c%+P88W9pr.4:aHX"1_,j3)rb*&4_f/BLM!TI?m;kki1><0+WDYiSXVr
qg?1#Z=e/1`\W[jkDMce5hJS_b_*)m*#dMg6clrNTsLd,63Gsglja6Wc
L=JQ-cO%F-#_(JOfc%9?Jn96aGd?jmHcdJR=a&mAaPa4L,eUYXT`aZ%C^R+"7HId-
HB=ns95b,aUQ-(F%ij/**Go8h8MJs1YY)Bj'=l!9nffTC`A^,eOus&-"lkf!!56YB
Zpp5Q9H@r6iO4c.EKubs0:K+j39B*^*<0(te2WGK#$fQ&rc:BT!fcd/oq@?\
C#].9YB5R=32"A@-u!-jVc[CcVXddd%:".A*8K3sNW)DBM7I5X'pmFnM,hu;SS^!4
5qpb=EPEO7,S+iBb:3r/a7HnhWP*K@Hj#k#P5AQZ>QC]o.]F`_3c98A%e)IO'ZlX,
32.D$Eo.)S(=aR.X-$I\g6f%CYLOMJKLpRQ_7(uXcA8Og@B.+P18H,,aq\7ILhh6>
G?`]:XIfnqI+CkMcD,K5b,W^p$GS=5WaqfBJ6er)LrAWLN/$YgMaYd7q@3/1NpH&t
*$(>Vl`?_P(gu"I#mE53VuqJC0]mphd=qOK$VN@6q\oDVQf@Cpoc]SVQ"gAQ3p8pW
%r[2T^Y=h6_D9!:9#E^`aUrFW#f&4JNipH&9%>4:KT6a)9lrC1[Tj?ci(%A]VYX`NlL7^BJr+^jIR&ph3o[9f8Zq1UG`d4I*ATSNd2@8Va
7[=;R$hQe;0%eUoeaReEV02H[Ap=/Fpp3c$Y5nXtbs4\~>
endstream
endobj
46 0 obj
[/Indexed/DeviceRGB 255 45 0 R]
endobj
45 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
77 0 obj
<>
endobj
65 0 obj
<>
endobj
101 0 obj
<>
endobj
121 0 obj
<>
endobj
66 0 obj
<>
endobj
92 0 obj
<>stream
HtUiTj6@\E8d%PTTDq EF[Ah@d!:čL0j0רD'fr2CsI&?9'9{}{'#,-L6eCڀj4iщ RQM.2B䢓%7eg!v~<d?L?[;tC.*ɬ[/Eܕ&̎,;a?zo}&6e4Iaurl^ND!d"A4tƂ Di8MR>AHjS2u7PNΰ'ƠF?g~_2i2b1ٖ@,$%F f*1"@Wvh+jVH^~*O۴6urútRJį7dyzT
(Z'fzZf(bpW9p,03Ib C{e";1|HѺ|K);2nPK;$~Ja2 +w{Гp=k{%SB0 .:6IO$fP2߃tX;:,~:>+یٟgtvIⲩ'{@ `e݆XY#a˦J_?cAClsg-]Z[AOF~-{bLը2{ {Q3,`."^<|GY+,|aM78C!j+`JZ j֩ vβ=ClĩLgM6rsGLgXey:^<.*TϡjҘvs`;ЕUϺq@33|cB"NgvlJT*mrUȥ)n{ztJNԧ&J<y+-O%&
Z%-ohWAGXA}V6Ohs~*.%
+ջt'y陪=|m/Әw:Rp?/$r_U\TYkUFO6n~P%q
n$n>~25$,}}Q!i4H
B聤wZDU\. d æo?ȐmQ.ެa6V}kOoj*K|P/;a}b[ynE{Uǚ^ 'ԱȲSN)ZVT1x@%YFRXINd-Pe6֨D? CF%\_4e
zۺaA1ՍόԥsIq4gu;jEة*35(H8}V[
fe5bLKmTy0%ORiEuQ]X5.Ɖ7;=\#u{I